APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 64 filers reported holding APREA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $53 | -99.9% | 164,626 | +35.7% | 0.00% | – |
| Q3 2022 | $79,000 | +887.5% | 121,333 | +1083.2% | 0.00% | – |
| Q2 2022 | $8,000 | -95.1% | 10,255 | -69.1% | 0.00% | – |
| Q2 2021 | $162,000 | -65.8% | 33,203 | -65.5% | 0.00% | – |
| Q4 2020 | $473,000 | -2.5% | 96,227 | +377.4% | 0.00% | -100.0% |
| Q3 2020 | $485,000 | -38.5% | 20,157 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $788,000 | +170.8% | 20,315 | +220.3% | 0.00% | – |
| Q4 2019 | $291,000 | – | 6,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 1,377,654 | $6,778,000 | 2.28% |
| Versant Venture Management, LLC | 1,426,328 | $7,018,000 | 0.73% |
| COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $206,000 | 0.38% |
| Redmile Group, LLC | 1,268,718 | $6,242,000 | 0.08% |
| Gyon Technologies Capital Management, LP | 41,801 | $206,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 163,681 | $805,000 | 0.06% |
| Palo Alto Investors LP | 128,770 | $634,000 | 0.03% |
| Walleye Capital LLC | 100,800 | $496,000 | 0.03% |
| Virtus ETF Advisers LLC | 10,261 | $50,000 | 0.02% |
| Candriam S.C.A. | 362,346 | $1,783,000 | 0.01% |